IL1 Inhibition in FOP — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

IL1 Inhibition in FOP — Stella

Recruiting

Back to Fibrodysplasia Ossificans Progressiva (FOP) trials

Trial locations(1 site)

United States

UCSF, San Francisco, California

Key details

Sponsor

University of California, San Francisco

Collaborators

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Enrollment target

~11 participants

Started

April 2025

Primary completion

March 2027

Age range

6 Years – 30 Years

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov